12936 Results

People

  1. Weigelt
    Weigelt
  2. Reis-Filho
    Reis-Filho
  3. Gonen
    Gonen
  4. Ladanyi
    Ladanyi
  5. Berger
    Berger
  6. Deasy
    Deasy
  7. Solit
    Solit
  8. Lewis
    Lewis
  9. Schultz
    Schultz
  10. De Stanchina
    De Stanchina

Groups

  1. Sloan Kettering Institute Postdocs (12936)
  2. GSK Faculty (6210)
  3. Department of Medicine (4656)
  4. Sloan Kettering Institute Faculty (3490)
  5. Surgery (2557)
  6. Solid Tumor Oncology Division (2525)
  7. Department of Pathology and Laboratory Medicine (2500)
  8. Center for Hematologic Malignancies (2324)
  9. Epidemiology and Biostatistics (1997)
  10. Human Oncology and Pathogenesis Program (1984)
  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (7820)
  2. Meeting Abstract (3612)
  3. Review (610)
  4. Editorial (251)
  5. Book Section (189)
  6. Conference Paper (160)
  7. Research Letter (133)
  8. Correspondence (63)
  9. Miscellaneous (62)
  10. Guidelines (30)
  11. Book Whole (6)
Groups
  1. Sloan Kettering Institute Postdocs (12936)
  2. GSK Faculty (6210)
  3. Department of Medicine (4656)
  4. Sloan Kettering Institute Faculty (3490)
  5. Surgery (2557)
  6. Solid Tumor Oncology Division (2525)

More Groups

People
  1. Britta Weigelt (366)
  2. Jorge Reis-Filho (327)
  3. Mithat Gonen (309)
  4. Marc Ladanyi (304)
  5. Joseph Deasy (278)
  6. Michael Berger (278)

More People

Years
  1. 2025 (394)
  2. 2024 (1038)
  3. 2023 (1151)
  4. 2022 (1364)
  5. 2021 (1176)
  6. 2020 (1240)

More Years

Publications
  1. Blood (641)
  2. Cancer Research (542)
  3. Journal of Clinical Oncology (416)
  4. Journal of Nuclear Medicine (261)
  5. Annals of Surgical Oncology (257)
  6. Clinical Cancer Research (235)

More Publications

Publishers
  1. Nature Publishing Group (1308)
  2. Elsevier Inc. (1173)
  3. American Association for Cancer Research (1039)
  4. Springer (818)
  5. Cell Press (719)
  6. American Society of Hematology (697)

More Publishers

Results (12936)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Enhanced adipogenesis of bone marrow-derived stromal cells by ovarian cancer cells via BMP4 and IL8 is associated with increase in cancer stem/progenitor cells and cancer cell proliferation
    Meeting Abstract

    Wong, E. W. P.; Shen, L. B.; Shieh, J.H.; Moore, M. A. S.
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Glioma-associated IDH mutation induces miR-34a repression and stem cell-like physiology through enhanced PDGF signaling
    Meeting Abstract

    Silber, J.; Harinath, G.; Parthasarathy, P. T.; Fabius, A. W. M.; Turcan, S.; Chan, T. A.; Huse, J. T.
    Cancer Research (2014)

    Fulltext@MSK | Save
  • The antitumor effects of PI3K beta inhibitors in PTEN negative prostate cancer are enhanced by inhibition of reactivated PI3K alpha signaling
    Meeting Abstract

    Schwartz, S.; Carver, B. S.; Wongvipat, J.; Rodrik-Outmezguine, V. ; Destanchina, E.; Trigwell, C.; Barry, S.; Baselga, J.; Chandarlapaty, S.; Scher, H. I.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Blockade of EGFR and HER3 enhances PI3K/Akt antitumor activity in triple negative breast cancer
    Meeting Abstract

    Scaltriti, M.; Tao, J.; Castel, P.; Radosevic-Robin, N.; Elkabets, M.; Auricchio, N.; Juric, D.; Penault-Llorca, F.; Baselga, J.
    Cancer Research (2014)

    Fulltext@MSK | Save
  • PNA as novel targeted cancer therapy for BRAF(V600E) mutant melanoma
    Meeting Abstract

    Rothman, J. H.; Surriga, O.; Vasudeva, S. D.; Ambrosini, G.; Ouerfelli, O.; Schwartz, G. K.
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Acquired resistance to rapamycin and mTOR kinase inhibitors is mediated by non-overlapping mutations in distinct sites in the mTOR protein
    Meeting Abstract

    Rodrik - Outmezguine, V. S.; Yao, Z.; Mukherjee, R.; Cai, L.; Barratt, D.; Ward, R.; Klinowska, T.; Destanchina, E.; Berger, M.; Baselga, J.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Dual lineage inhibition of ETV1 and KIT disrupts the ETV1-KIT feed forward circuit and potentiates imatinib antitumor effect in GIST oncogenesis
    Meeting Abstract

    Ran, L.; Sirota, I.; Cao, Z.; Murphy, D.; Shukla, S.; Rossi, F.; Wongvipat, J.; Tap, W. D.; Besmer, P.; Antonescu, C. R.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Bioenergetics of T cells in the context of adoptive immunotherapy
    Meeting Abstract

    Moroz, E.; Moroz, M.; Serganova, I.; Zurita, J.; Lee, J.; Shah, N.; Ponomarev, V.; Blasberg, R.
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Context specific effects of the BRAFV600E mutation on hematopoiesis identifies novel models of BRAF mutant hematopoietic disorders
    Meeting Abstract

    Kim, E.; Chung, S. S.; Park, J. H.; Chung, Y. R.; Lito, P.; Feldstein, J.; Hu, W. H.; Beguilin, W.; Monette, S.; Duy, C.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Novel function of the BAP1 nuclear deubiquitinase in the non-homologous end joining (NHEJ) pathway of double strand DNA repair
    Meeting Abstract

    Ito, T.; Kitano, S.; Erdjument-Bromage, H.; Ladanyi, M.
    Cancer Research (2014)

    Fulltext@MSK | Save